Nonetheless, other cell lineage-specific transcription factors have been found amplified in cancers, including MITF in melanoma [32], AR in hormone-independent prostate cancer [33], ESR1 in breast cancer [34], and most recently NKX2-1 (TITF) in lung cancer [17], [35]–[37]. This evidence concerns the gene ESR1 and lung carcinoma.